Related topics: Clinical Development
Mr Gareth Macdonald
Mr Lee S Scheible
Sourcing consultant & relationship manager - Oncology
The way drug companies work with CROs is evolving, with the emphasis shifting from the client-service provider model to a more strategic, long-term relationship focused approach.
This presentation will discuss the role strategic partnerships can play in trialling cancer drugs with specific examples from current high-profile collaboration.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
The way drug companies work with CROs is evolving, with the emphasis shifting from the...
Recruiting patients is often, if not always, the most expensive and time consuming part of...
On average over half the cost of developing a new cancer drug is associated with...